These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38442535)

  • 21. Treatment provider perceptions of take-home methadone regulation before and during COVID-19.
    Madden EF; Christian BT; Lagisetty PA; Ray BR; Sulzer SH
    Drug Alcohol Depend; 2021 Nov; 228():109100. PubMed ID: 34600251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss, liberation, and agency: Patient experiences of methadone treatment at opioid treatment programs during the COVID-19 pandemic.
    López-Castro T; Jakubowski A; Masyukova M; Peterson M; Pierz A; Kodali S; Arnsten JH; Starrels JL; Nahvi S
    J Subst Use Addict Treat; 2024 Feb; 157():209235. PubMed ID: 38061636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era.
    Amram O; Amiri S; Panwala V; Lutz R; Joudrey PJ; Socias E
    Am J Drug Alcohol Abuse; 2021 Nov; 47(6):722-729. PubMed ID: 34670453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient experiences of methadone treatment changes during the first wave of COVID-19: a national community-driven survey.
    Brothers S; Palayew A; Simon C; Coulter A; Strichartz K; Voyles N; Vincent L
    Harm Reduct J; 2023 Mar; 20(1):31. PubMed ID: 36894968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID.
    Meyerson BE; Bentele KG; Russell DM; Brady BR; Downer M; Garcia RC; Garnett I; Lutz R; Mahoney A; Samorano S; Arredondo C; Andres HJ; Coles H; Granillo B
    PLoS One; 2022; 17(10):e0274094. PubMed ID: 36282806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methadone maintenance treatment and mortality in people with criminal convictions: A population-based retrospective cohort study from Canada.
    Russolillo A; Moniruzzaman A; Somers JM
    PLoS Med; 2018 Jul; 15(7):e1002625. PubMed ID: 30063699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients' perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study.
    Scott G; Turner S; Lowry N; Hodge A; Ashraf W; McClean K; Kelleher M; Mitcheson L; Marsden J
    BMJ Open; 2023 Mar; 13(3):e069857. PubMed ID: 36944465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Sign Me Up": a qualitative study of video observed therapy (VOT) for patients receiving expedited methadone take-homes during the COVID-19 pandemic.
    Darnton JB; Bhatraju EP; Beima-Sofie K; Michaels A; Hallgren KA; Soth S; Grekin P; Woolworth S; Tsui JI
    Addict Sci Clin Pract; 2023 Mar; 18(1):21. PubMed ID: 36991506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study.
    Oviedo-Joekes E; MacDonald S; Boissonneault C; Harper K
    Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):22. PubMed ID: 33673847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incremental expenditures attributable to daily dispensation and witnessed ingestion for opioid agonist treatment in British Columbia: 2014-20.
    Nosyk B; Kurz M; Guerra-Alejos BC; Piske M; Dale L; Min JE
    Addiction; 2023 Jul; 118(7):1376-1380. PubMed ID: 36772838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revising our attitudes towards agonist medications and their diversion in a time of pandemic.
    Del Pozo B; Rich JD
    J Subst Abuse Treat; 2020 Dec; 119():108139. PubMed ID: 33138924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mobile methadone dispensing in Delhi, India: implementation research.
    Rao R; Yadav D; Bhad R; Rajhans P
    Bull World Health Organ; 2021 Jun; 99(6):422-428. PubMed ID: 34108752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication Adherence in Patients Undergoing Methadone Maintenance Treatment in Xi'an, China.
    Zhou K; Li H; Wei X; Li X; Zhuang G
    J Addict Med; 2017; 11(1):28-33. PubMed ID: 27649264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient perspectives on community pharmacy administered and dispensing of methadone treatment for opioid use disorder: a qualitative study in the U.S.
    Wu LT; John WS; Mannelli P; Morse ED; Anderson A; Schwartz RP
    Addict Sci Clin Pract; 2023 Aug; 18(1):45. PubMed ID: 37533071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "It's like 'liquid handcuffs": The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients' lives.
    Frank D; Mateu-Gelabert P; Perlman DC; Walters SM; Curran L; Guarino H
    Harm Reduct J; 2021 Aug; 18(1):88. PubMed ID: 34391436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "No home to take methadone to": Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston.
    Harris MTH; Lambert AM; Maschke AD; Bagley SM; Walley AY; Gunn CM
    J Subst Abuse Treat; 2022 Apr; 135():108655. PubMed ID: 34772604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shifting Medication Treatment Practices in the COVID-19 Pandemic: A Statewide Survey of Pennsylvania Opioid Treatment Programs.
    Krawczyk N; Maniates H; Hulsey E; Smith JS; DiDomenico E; Stuart EA; Saloner B; Bandara S
    J Addict Med; 2022 Nov-Dec 01; 16(6):645-652. PubMed ID: 35165225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series.
    Nielsen S; Bruno R; Degenhardt L; Demirkol A; Lintzeris N
    Drug Alcohol Rev; 2017 May; 36(3):311-316. PubMed ID: 27273511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England.
    Aldabergenov D; Reynolds L; Scott J; Kelleher MJ; Strang J; Copeland CS; Kalk NJ
    Int J Drug Policy; 2022 Dec; 110():103877. PubMed ID: 36265326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs.
    Jones CM; Compton WM; Han B; Baldwin G; Volkow ND
    JAMA Psychiatry; 2022 Sep; 79(9):932-934. PubMed ID: 35830198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.